Insulet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Insulet 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PODD

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. 

CEO
Ashley A. McEvoy
CEOAshley A. McEvoy
Employees
5,400
Employees5,400
Headquarters
Acton, Massachusetts
HeadquartersActon, Massachusetts
Founded
2000
Founded2000
Employees
5,400
Employees5,400

PODD Key Statistics

Market cap
11.87B
Market cap11.87B
Price-Earnings ratio
50.31
Price-Earnings ratio50.31
Dividend yield
Dividend yield
Average volume
1.37M
Average volume1.37M
High today
$175.39
High today$175.39
Low today
$171.02
Low today$171.02
Open price
$175.04
Open price$175.04
Volume
1.28M
Volume1.28M
52 Week high
$354.88
52 Week high$354.88
52 Week low
$158.35
52 Week low$158.35

Stock Snapshot

The current Insulet(PODD) stock price is $171.39, with a market capitalization of 11.87B. The stock trades at a price-to-earnings (P/E) ratio of 50.31.

On 2026-05-05, Insulet(PODD) stock traded between a low of $171.02 and a high of $175.39. Shares are currently priced at $171.39, which is +0.2% above the low and -2.3% below the high.

The Insulet(PODD)'s current trading volume is 1.28M, compared to an average daily volume of 1.37M.

During the past year, Insulet(PODD) stock moved between $158.35 at its lowest and $354.88 at its peak.

During the past year, Insulet(PODD) stock moved between $158.35 at its lowest and $354.88 at its peak.

PODD News

Simply Wall St 2d
Is It Time To Reassess Insulet After A 31.9% One-Year Share Price Fall

Wondering if Insulet at around US$175 still reflects its true worth, or if the recent price is out of sync with underlying value. Over the past year, the share...

Is It Time To Reassess Insulet After A 31.9% One-Year Share Price Fall
Simply Wall St 4d
Is Insulet Turning Device Corrections Into a Test of Its Innovation-Driven Risk Strategy?

Insulet Corporation recently issued a voluntary medical device correction affecting certain Omnipod 5 Pod lots, while continuing to highlight new clinical data,...

Is Insulet Turning Device Corrections Into a Test of Its Innovation-Driven Risk Strategy?
TipRanks 5d
Insulet Clarifies FDA Injury Reports on Device Correction

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Analyst ratings

85%

of 27 ratings
Buy
85.2%
Hold
11.1%
Sell
3.7%

More PODD News

TipRanks 6d
Insulet removes certain Omnipod 5 Pods, FDA announces

On March 12, Insulet (PODD) sent all affected customers a letter recommending they not use pods from affected lots, FDA reported. On April 10, Insulet sent all...

People also own

Based on the portfolios of people who own PODD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.